Gastric Cancer Epidemiology Initiative in Central America

中美洲胃癌流行病学倡议

基本信息

  • 批准号:
    7491696
  • 负责人:
  • 金额:
    $ 13.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-01 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Candidate: Douglas Morgan, MD MPH is an assistant professor of Medicine and Gastroenterology at the University of North Carolina. Career Development Plan: the candidate will conduct mentored research and participate in coursework to develop vital skills in translational research and implementation, to develop academic leadership. The candidate will be positioned to become leader in gastric cancer epidemiology in the U.S. and Latin America. Immediate Objective: to acquire expertise in cancer, nutrition, and genetic epidemiology methods with a focus upon gastric cancer. Long-term Objective: to decrease gastric cancer mortality in Latin America and the U.S. Latino population, through an in-depth epidemiology initiative in a high incidence region in Central America. Specific Aims: 1) Delineate the gastric cancer genetic susceptibility of the study population. 2) Determine if the H. pylori cagA virulence moiety is an independent risk factor. 3) Appraise dietary factors associated with gastric cancer in the region. Research Methods: case-control population-based study in Western Honduras, a region of high incidence (39 and 21 per 100K/year, M and F, respectively). Our preliminary data suggests that the region is a distinct epidemiologic niche, with unique gastric cancer genetic and environmental susceptibility. In aim 1, we will determine the host risk proinflammatory cytokine profile (IL-1B, IL-10, TNFa, IL-8). In aim 2, we will delineate the H. pylori and cagA virulence prevalence, and association with gastric cancer. In aim 3, we will assess dietary risk factors. We will construct multivariate models to assess the interaction between genetic, H. pylori and dietary factors, to our knowledge the first such investigation. Cumulative target enrollment is 500 cases and 500 controls. Environment: incident cases are recruited at the sole district hospital in Western Honduras, the site of an established, successful collaboration over the past 4 years. Population-based controls are recruited from villages, in the region. Data reduction and analysis, specimen processing, and specimen banking is within the UNC Center for Gastrointestinal Biology and Disease. Mentorship: primary mentorship will be provided Robert Sandier, MD MPH, a national leader in gastrointestinal cancer epidemiology. Secondary mentorship is facilitated with three successful researchers: an international leader in bacterial and H. pylori virulence (Dr Richard Peek, Vanderbilt University), a nutrition cancer epidemiologist (Dr Jessie Satia, UNC School of Public Health), and a genetic epidemiologist (Dr. Kari North, UNC School of Public Health). Relevance: gastric cancer is the second leading cause of global cancer mortality, important in Latin America, and preventable through initiatives in screening, bacterial eradication, and/or dietary intervention. This study, through systematic epidemiology, will provide detailed etiologic information, to target intervention programs in Latin America and possibly the growing U.S. Latino population.
描述(由申请人提供):候选人:道格拉斯摩根,医学博士MPH是医学和胃肠病学助理教授在北卡罗来纳州大学。职业发展计划:候选人将进行指导研究,并参加课程,以发展翻译研究和实施的重要技能,发展学术领导力。候选人将成为美国和拉丁美洲胃癌流行病学的领导者。近期目标:获得癌症,营养和遗传流行病学方法的专业知识,重点是胃癌。长期目标:通过在中美洲高发地区开展深入的流行病学倡议,降低拉丁美洲和美国拉丁裔人口的胃癌死亡率。具体目的:1)阐明研究人群胃癌的遗传易感性。2)确定H. pylori cagA毒力部分是一个独立的危险因素。3)评估该地区与胃癌相关的饮食因素。研究方法:在洪都拉斯西部进行的病例对照人群研究,该地区是一个高发地区(男性和女性分别为39例和21例/10万/年)。我们的初步数据表明,该地区是一个独特的流行病学生态位,具有独特的胃癌遗传和环境易感性。在目标1中,我们将确定宿主风险促炎细胞因子谱(IL-1B、IL-10、TNF α、IL-8)。在目标2中,我们将描述H。pylori和cagA毒力流行率以及与胃癌的关系。在目标3中,我们将评估饮食风险因素。我们将构建多变量模型来评估遗传、H. pylori和饮食因素,据我们所知,第一次这样的调查。累积目标入组为500例病例和500例对照。工作环境:在洪都拉斯西部唯一的地区医院招募了事故病例,过去4年来,该医院一直是成功的合作地点。以人口为基础的控制是从该地区的村庄招募的。数据简化和分析,标本处理和标本库是在胃肠道生物学和疾病中心。导师:主要导师将提供罗伯特桑迪耶,医学博士公共卫生硕士,在胃肠道癌症流行病学的国家领导人。三位成功的研究人员为二级指导提供了便利:细菌和H. pylori毒力(Richard Peek博士,范德比尔特大学),营养癌症流行病学家(杰西Satia博士,斯坦福公共卫生学院)和遗传流行病学家(Kari North博士,斯坦福公共卫生学院)。相关性:胃癌是全球癌症死亡率的第二大原因,在拉丁美洲是重要的,并且可以通过筛查、细菌根除和/或饮食干预来预防。这项研究,通过系统流行病学,将提供详细的病因学信息,针对拉丁美洲的干预计划,并可能不断增长的美国拉丁裔人口。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Douglas Morgan其他文献

Douglas Morgan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Douglas Morgan', 18)}}的其他基金

Targeted chemoprevention of gastric carcinogenesis in high risk populations
高危人群胃癌的靶向化学预防
  • 批准号:
    9126254
  • 财政年份:
    2014
  • 资助金额:
    $ 13.6万
  • 项目类别:
Targeted chemoprevention of gastric carcinogenesis in high risk populations
高危人群胃癌的靶向化学预防
  • 批准号:
    8799582
  • 财政年份:
    2014
  • 资助金额:
    $ 13.6万
  • 项目类别:
Targeted chemoprevention of gastric carcinogenesis in high risk populations
高危人群胃癌的靶向化学预防
  • 批准号:
    8929196
  • 财政年份:
    2014
  • 资助金额:
    $ 13.6万
  • 项目类别:
Targeted chemoprevention of gastric carcinogenesis in high risk populations
高危人群胃癌的靶向化学预防
  • 批准号:
    9248746
  • 财政年份:
    2014
  • 资助金额:
    $ 13.6万
  • 项目类别:
Targeted chemoprevention of gastric carcinogenesis in high risk populations
高危人群胃癌的靶向化学预防
  • 批准号:
    9321431
  • 财政年份:
    2014
  • 资助金额:
    $ 13.6万
  • 项目类别:
H. pylori ancestral haplotype a gastric cancer risk determinant in Latin America
幽门螺杆菌祖先单倍型是拉丁美洲胃癌风险决定因素
  • 批准号:
    8510827
  • 财政年份:
    2013
  • 资助金额:
    $ 13.6万
  • 项目类别:
H. pylori ancestral haplotype a gastric cancer risk determinant in Latin America
幽门螺杆菌祖先单倍型是拉丁美洲胃癌风险决定因素
  • 批准号:
    8633019
  • 财政年份:
    2013
  • 资助金额:
    $ 13.6万
  • 项目类别:
Gastric Cancer Epidemiology Initiative in Central America
中美洲胃癌流行病学倡议
  • 批准号:
    7688491
  • 财政年份:
    2007
  • 资助金额:
    $ 13.6万
  • 项目类别:
Gastric Cancer Epidemiology Initiative in Central America
中美洲胃癌流行病学倡议
  • 批准号:
    7317576
  • 财政年份:
    2007
  • 资助金额:
    $ 13.6万
  • 项目类别:
Gastric Cancer Epidemiology Initiative in Central America
中美洲胃癌流行病学倡议
  • 批准号:
    8133452
  • 财政年份:
    2007
  • 资助金额:
    $ 13.6万
  • 项目类别:

相似国自然基金

大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
  • 批准号:
    30840003
  • 批准年份:
    2008
  • 资助金额:
    12.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
  • 批准号:
    478914
  • 财政年份:
    2023
  • 资助金额:
    $ 13.6万
  • 项目类别:
    Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
  • 批准号:
    23K14913
  • 财政年份:
    2023
  • 资助金额:
    $ 13.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
  • 批准号:
    23K15035
  • 财政年份:
    2023
  • 资助金额:
    $ 13.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
  • 批准号:
    10657069
  • 财政年份:
    2023
  • 资助金额:
    $ 13.6万
  • 项目类别:
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
  • 批准号:
    10442874
  • 财政年份:
    2023
  • 资助金额:
    $ 13.6万
  • 项目类别:
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
  • 批准号:
    23H02698
  • 财政年份:
    2023
  • 资助金额:
    $ 13.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
  • 批准号:
    23K08326
  • 财政年份:
    2023
  • 资助金额:
    $ 13.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
  • 批准号:
    23K14614
  • 财政年份:
    2023
  • 资助金额:
    $ 13.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
  • 批准号:
    23K15075
  • 财政年份:
    2023
  • 资助金额:
    $ 13.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
  • 批准号:
    10743611
  • 财政年份:
    2023
  • 资助金额:
    $ 13.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了